跳至主要内容
临床试验/NL-OMON33514
NL-OMON33514已完成不适用

The effects of vitamin D3 supplementation on the T cell compartment in Multiple Sclerosis; a pilot-study - Vitamin D3 supplementation and the T cel compartment in MS

niversiteit Maastricht0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Relapsing Remitting MS (Revised McDonald criteria 2005)
  • - Disease duration since MS-onset <6 years
  • - At start of study >6 weeks in remission
  • - Use of Interferon Beta (1a or 1b) as immune modulation
  • - Age > 18 years

排除标准

  • - Progressive MS phenotype
  • - Relapse <6 weeks before start study
  • - Abnormalities of vitamin D hormonal system other than low dietary intake or limited sun exposure (i.e. malabsorption, chirrosis, nephrotic syndrome, hyperthyreoidism, renal faillure, rickets, hypoparathyreoidism, kown malignancy, granulomatous disorders (tuberculosis, sarcoidosis, silicosis), and lymphomas).
  • - Intake of drugs that influence vitamin D homeostasis other than corticosteroids (i.e. Orlistat, anticonvulsants).
  • - Conditions with an increased susceptibility to hypercalcemia (known arrythmia or heart disease, treatment with digitalis or hydrochlorothiazide and those who suffer from nephrolithiasis).
  • - Frequent use of tanning beds (>1 time/week)
  • - Alcohol or drug abuse
  • - Pregnancy or the intention to become pregnant during the study period

研究者

相似试验